NCT06233240View on ClinicalTrials.gov

Sitagliptin and Metformin Hydrochloride Tablets 50 mg/1000 mg Relative to Originator

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

April 30, 2024

Primary Completion Date

May 29, 2024

Study Completion Date

June 12, 2024

Conditions
Healthy Subjects
Interventions
DRUG

Sitagliptin and Metformin Hydrochloride Tablets Test product

Sitagliptin and Metformin Hydrochloride Tablets 50 mg/1000 mg Manufactured by: Mankind Pharma Limited, India

DRUG

Sitagliptin and Metformin Hydrochloride Tablets Reference product

Sitagliptin and Metformin Hydrochloride Tablets 50 mg/1000 mg Manufactured by: Patheon Puerto Rico, Puerto Rico 00674

All Listed Sponsors
lead

Bio-innova Co., Ltd

INDUSTRY